Literature DB >> 6203303

Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion.

H Moi.   

Abstract

In a defined area of 273 000 inhabitants in Central Sweden a total number of 125 patients with dermatitis herpetiformis (DH) were observed during the years 1974-1982. The incidence was calculated for the years 1943-1982 and was found to be 0.86-1.45 patients/100 000 inhabitants/year, which is in agreement with a report from Finland. However, the prevalence of DH in the area was 39.2 patients/100 000 inhabitants, which is much higher than previously reported. Spontaneous transient remissions of more than half a year duration were seen in 20% of the patients. At the end of the study, 16 out of 37 patients (43%) on normal diet used no dapsone because of no or minimal rash. Immunohistochemical demonstration of IgA-deposits at the dermoepidermal junction was found to be a good diagnostic criterion. Granular deposits were seen in all except one patient, also in those needing no dapsone. Five out of 6 patients with a granular-linear pattern were still alive at the end of the study, and all of them needed dapsone for control of the rash.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203303

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  2 in total

1.  Antiendomysial antibody--useful serological indicator of dermatitis herpetiformis.

Authors:  V Kumar; E H Beutner; T P Chorzelski
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 2.  Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years.

Authors:  Chika Ohata; Norito Ishii; Takahiro Hamada; Yutaka Shimomura; Hironori Niizeki; Teruki Dainichi; Minao Furumura; Daisuke Tsuruta; Takashi Hashimoto
Journal:  Clin Dev Immunol       Date:  2012-06-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.